Armistice Capital, LLC 13D/13G Filings for XORTX Therapeutics Inc. (XRTX)

Armistice Capital, LLC 13D and 13G filings for XORTX Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
5:04 pm
Purchase		 2024-12-31 13G XORTX Therapeutics Inc.
XRTX		 Armistice Capital, LLC 346,807
9.990%		 177,017increase
(+104.26%)		 Filing
2024-02-14
3:03 pm
Purchase		 2023-12-31 13G XORTX Therapeutics Inc.
XRTX		 Armistice Capital, LLC 169,790
4.990%		 169,790increase
(New Position)		 Filing